| __timestamp | United Therapeutics Corporation | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 381287000 | 40786000 |
| Thursday, January 1, 2015 | 452612000 | 47876000 |
| Friday, January 1, 2016 | 316800000 | 52035000 |
| Sunday, January 1, 2017 | 330100000 | 55348000 |
| Monday, January 1, 2018 | 265800000 | 65276000 |
| Tuesday, January 1, 2019 | 336200000 | 82720000 |
| Wednesday, January 1, 2020 | 423900000 | 89118000 |
| Friday, January 1, 2021 | 467000000 | 181193000 |
| Saturday, January 1, 2022 | 487000000 | 174078000 |
| Sunday, January 1, 2023 | 477100000 | 184232000 |
Unlocking the unknown
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding the financial strategies of key players is crucial. Over the past decade, United Therapeutics Corporation and Veracyte, Inc. have demonstrated distinct approaches to managing their Selling, General, and Administrative (SG&A) expenses.
United Therapeutics has consistently maintained higher SG&A expenses, peaking in 2022 with a 28% increase from 2014. This reflects their aggressive investment in marketing and administrative capabilities. In contrast, Veracyte, Inc. has shown a remarkable growth trajectory, with SG&A expenses surging by over 350% from 2014 to 2023, indicating their rapid expansion and scaling efforts.
These trends highlight the contrasting strategies of a well-established pharmaceutical giant and a burgeoning biotech firm, offering valuable insights into their operational priorities and market positioning.
Amgen Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sanofi vs Veracyte, Inc. Trends and Insights
Comparing SG&A Expenses: Bristol-Myers Squibb Company vs United Therapeutics Corporation Trends and Insights
Zoetis Inc. or United Therapeutics Corporation: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: GSK plc vs Veracyte, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Axsome Therapeutics, Inc.
Who Optimizes SG&A Costs Better? United Therapeutics Corporation or Amicus Therapeutics, Inc.
Who Optimizes SG&A Costs Better? United Therapeutics Corporation or Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Ionis Pharmaceuticals, Inc. and Veracyte, Inc.
Selling, General, and Administrative Costs: ADMA Biologics, Inc. vs Veracyte, Inc.